CLINICAL OBSERVATION OF THE USE OF ORAL VINORELBINE IN THE TREATMENT OF DISSEMINATED ESTROGEN-RECEPTORPOSITIVE, HER2-NEGATIVE BREAST CANCER. Wor.Bul.Soc.Sci. 2022;7:1-4. Accessed March 31, 2026. https://scholarexpress.net/index.php/wbss/article/view/514